Ex ante economic evaluation of genetic testing for the ARG389 beta1-adrenergic receptor polymorphism to support bucindolol treatment decisions in Stage III/IV heart failure
Nimer S. Alkhatib, Kenneth Ramos, Marion Slack, Brian Erstad, Mahdi Gharaibeh, Walter Klimecki, Jason H. Karnes, Nancy K. Sweitzer, Ivo Abraham
Dive into the research topics of 'Ex ante economic evaluation of genetic testing for the ARG389 beta1-adrenergic receptor polymorphism to support bucindolol treatment decisions in Stage III/IV heart failure'. Together they form a unique fingerprint.
Keyphrases
Nursing and Health Professions
Medicine and Dentistry
Biochemistry, Genetics and Molecular Biology
Agricultural and Biological Sciences
Pharmacology, Toxicology and Pharmaceutical Science